mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.088 |
0.07 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |